Document Details
Form
Filing Date
Apr 3, 2018
Document Date
Apr 3, 2018
Form Description
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Filing Group
Registration Statements
Company
Apellis Pharmaceuticals, Inc.
Issuer
APELLIS PHARMACEUTICALS, INC.